Bluesky Facebook Reddit Email

Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe COVID-1

07.22.20 | JAMA Network

Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

What The Study Did: This case series examines whether interleukin 7 (IL-7) is associated with restored host protective immunity in patients with severe COVID-19 and immunosuppression.

Authors: Pierre Francois Laterre, M.D., of the Université Catholique de Louvain in Brussels, Belgium, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.16485)

Editor's Note: The article includes funding/support and conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.16485?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072220

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

###

JAMA Network Open

Keywords

Article Information

Contact Information

JAMA Network Media Relations
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2020, July 22). Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe COVID-1. Brightsurf News. https://www.brightsurf.com/news/LRDV05G8/association-of-interleukin-7-immunotherapy-with-lymphocyte-counts-among-patients-with-severe-covid-1.html
MLA:
"Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe COVID-1." Brightsurf News, Jul. 22 2020, https://www.brightsurf.com/news/LRDV05G8/association-of-interleukin-7-immunotherapy-with-lymphocyte-counts-among-patients-with-severe-covid-1.html.